Cramer Opines on Icahn's Herbalife (HLF) Disclosure; Still Not Taking Sides
Get Alerts HLF Hot Sheet
Join SI Premium – FREE
Following Carl Icahn's disclosure of a near-13 percent stake in Herbalife (NYSE: HLF), splitting the hopes of a few short sellers in the process, Jim Cramer is out with a few comments Friday morning via the Twitter machine. Notably, following the spat between Icahn and Pershing Square's Bill Ackman in late January, Cramer recommended to stay away from Herbalife, with much of the recent movement being ego-based, not based on fundamentals.
* "[Herbalife] is now no longer about short squeeze. It is about making this a terminal short, like when i was short Noxell.."
* "Ackman wants Nobel Peace Prize, Icahn just wants to make money..."
* "Ackman must keep pressure on FTC NOW. His best hope"
* "Ackman must do under cover documentary of $HLF practices that he sees that are wrong and get emails from top--needs subpoena power tho"
Notably, Cramer also posted a message at the end of January which read: "i am not backing anyone in $HLF fight." So, there you have it, Cramer's side in Herbalife is to take none. Like the Switzerland of stock traders.
Herbalife is up 12.5 percent Friday.
* "[Herbalife] is now no longer about short squeeze. It is about making this a terminal short, like when i was short Noxell.."
* "Ackman wants Nobel Peace Prize, Icahn just wants to make money..."
* "Ackman must keep pressure on FTC NOW. His best hope"
* "Ackman must do under cover documentary of $HLF practices that he sees that are wrong and get emails from top--needs subpoena power tho"
Notably, Cramer also posted a message at the end of January which read: "i am not backing anyone in $HLF fight." So, there you have it, Cramer's side in Herbalife is to take none. Like the Switzerland of stock traders.
Herbalife is up 12.5 percent Friday.
Create E-mail Alert Related Categories
Insiders' BlogRelated Entities
Jim Cramer, Carl Icahn, William Ackman, Pershing Square Capital, TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share